Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma.
about
Diagnostic accuracy of ELISA for detecting serum Midkine in cancer patients.Midkine is a serum and urinary biomarker for the detection and prognosis of non-small cell lung cancer.Evidence that circulating proteins are more promising than miRNAs for identification of patients with squamous cell carcinoma of the tongue.Serum, plasma and saliva biomarkers for head and neck cancer.Effect of midkine on gemcitabine resistance in biliary tract cancer.Prognostic value of Midkine expression in patients with solid tumors: a systematic review and meta-analysis.
P2860
Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Serum midkine as a biomarker f ...... neck squamous cell carcinoma.
@ast
Serum midkine as a biomarker f ...... neck squamous cell carcinoma.
@en
type
label
Serum midkine as a biomarker f ...... neck squamous cell carcinoma.
@ast
Serum midkine as a biomarker f ...... neck squamous cell carcinoma.
@en
prefLabel
Serum midkine as a biomarker f ...... neck squamous cell carcinoma.
@ast
Serum midkine as a biomarker f ...... neck squamous cell carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Serum midkine as a biomarker f ...... neck squamous cell carcinoma.
@en
P2093
Akihiro Shiotani
Daisuke Kamide
Daisuke Mizokami
Hideaki Shimada
Hiroshi Suzuki
Koji Araki
Masayuki Tomifuji
Nobuaki Tanaka
Shingo Tanaka
Taku Yamashita
P2860
P304
P356
10.1002/CAM4.600
P407
P577
2016-01-22T00:00:00Z